APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Candidiasis Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Candidiasis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17397448032 January 2026199 pages

Choose your research edition.

Industry ResearchCandidiasis Drug Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Candidiasis Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Candidiasis Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Candidiasis Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Candidiasis Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Candidiasis Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Candidiasis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Candidiasis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Candidiasis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Candidiasis Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Candidiasis Drug include Bristol-Myers Squibb, Cisen Pharmaceutical, Effik, Kingyork Group, Perrigo, Bayer, Pfizer, J & J and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Candidiasis Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Candidiasis Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Candidiasis Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Candidiasis Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Candidiasis Drug Segment by Company

Bristol-Myers Squibb

Cisen Pharmaceutical

Effik

Kingyork Group

Perrigo

Bayer

Pfizer

J & J

Sanofi

Teva

Candidiasis Drug Segment by Type

Oral

External Use

Other

Candidiasis Drug Segment by Application

Hospital

Retail Pharmacy

Other

Candidiasis Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Candidiasis Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Candidiasis Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Candidiasis Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Candidiasis Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Candidiasis Drug industry.

Chapter 3: Detailed analysis of Candidiasis Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Candidiasis Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Candidiasis Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oral Table 3. Key Players of External Use Table 4. Key Players of Other Table 4. Global Candidiasis Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Retail Pharmacy Table 7. Key Players of Other Table 8. Global Candidiasis Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Candidiasis Drug Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Candidiasis Drug Market Share by Region (2021-2026) Table 11. Global Candidiasis Drug Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Candidiasis Drug Market Share by Region (2027-2032) Table 13. Candidiasis Drug Industry Trends Table 14. Candidiasis Drug Industry Drivers Table 15. Candidiasis Drug Industry Opportunities and Challenges Table 16. Candidiasis Drug Industry Restraints Table 17. Global Candidiasis Drug Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Candidiasis Drug Revenue Market Share by Company (2021-2026) Table 19. Global Candidiasis Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Candidiasis Drug Key Company Head Office and Area Served Table 21. Global Candidiasis Drug Company, Product Type & Application Table 22. Global Candidiasis Drug Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Candidiasis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Candidiasis Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Candidiasis Drug Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Candidiasis Drug Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Candidiasis Drug Revenue Market Share by Type (2021-2026) Table 29. Global Candidiasis Drug Revenue Market Share by Type (2027-2032) Table 30. Global Candidiasis Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Candidiasis Drug Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Candidiasis Drug Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Candidiasis Drug Revenue Market Share by Application (2021-2026) Table 34. Global Candidiasis Drug Revenue Market Share by Application (2027-2032) Table 35. Bristol-Myers Squibb Company Information Table 36. Bristol-Myers Squibb Business Overview Table 37. Bristol-Myers Squibb Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Bristol-Myers Squibb Candidiasis Drug Product Portfolio Table 39. Bristol-Myers Squibb Recent Development Table 40. Cisen Pharmaceutical Company Information Table 41. Cisen Pharmaceutical Business Overview Table 42. Cisen Pharmaceutical Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Cisen Pharmaceutical Candidiasis Drug Product Portfolio Table 44. Cisen Pharmaceutical Recent Development Table 45. Effik Company Information Table 46. Effik Business Overview Table 47. Effik Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Effik Candidiasis Drug Product Portfolio Table 49. Effik Recent Development Table 50. Kingyork Group Company Information Table 51. Kingyork Group Business Overview Table 52. Kingyork Group Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Kingyork Group Candidiasis Drug Product Portfolio Table 54. Kingyork Group Recent Development Table 55. Perrigo Company Information Table 56. Perrigo Business Overview Table 57. Perrigo Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Perrigo Candidiasis Drug Product Portfolio Table 59. Perrigo Recent Development Table 60. Bayer Company Information Table 61. Bayer Business Overview Table 62. Bayer Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Bayer Candidiasis Drug Product Portfolio Table 64. Bayer Recent Development Table 65. Pfizer Company Information Table 66. Pfizer Business Overview Table 67. Pfizer Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Pfizer Candidiasis Drug Product Portfolio Table 69. Pfizer Recent Development Table 70. J & J Company Information Table 71. J & J Business Overview Table 72. J & J Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. J & J Candidiasis Drug Product Portfolio Table 74. J & J Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Sanofi Candidiasis Drug Product Portfolio Table 79. Sanofi Recent Development Table 80. Teva Company Information Table 81. Teva Business Overview Table 82. Teva Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Teva Candidiasis Drug Product Portfolio Table 84. Teva Recent Development Table 85. North America Candidiasis Drug Market Size by Type (2021-2026) & (US$ Million) Table 86. North America Candidiasis Drug Market Size by Type (2027-2032) & (US$ Million) Table 87. North America Candidiasis Drug Market Size by Application (2021-2026) & (US$ Million) Table 88. North America Candidiasis Drug Market Size by Application (2027-2032) & (US$ Million) Table 89. North America Candidiasis Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America Candidiasis Drug Market Size by Country (2021-2026) Table 91. North America Candidiasis Drug Market Size by Country (2027-2032) Table 92. Europe Candidiasis Drug Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe Candidiasis Drug Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe Candidiasis Drug Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe Candidiasis Drug Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe Candidiasis Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe Candidiasis Drug Market Size by Country (2021-2026) Table 98. Europe Candidiasis Drug Market Size by Country (2027-2032) Table 99. China Candidiasis Drug Market Size by Type (2021-2026) & (US$ Million) Table 100. China Candidiasis Drug Market Size by Type (2027-2032) & (US$ Million) Table 101. China Candidiasis Drug Market Size by Application (2021-2026) & (US$ Million) Table 102. China Candidiasis Drug Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia Candidiasis Drug Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia Candidiasis Drug Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia Candidiasis Drug Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia Candidiasis Drug Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia Candidiasis Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia Candidiasis Drug Market Size by Country (2021-2026) Table 109. Asia Candidiasis Drug Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa Candidiasis Drug Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa Candidiasis Drug Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa Candidiasis Drug Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa Candidiasis Drug Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa Candidiasis Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa Candidiasis Drug Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa Candidiasis Drug Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Candidiasis Drug Product Image Figure 2. Global Candidiasis Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Candidiasis Drug Market Share by Type: 2025 VS 2032 Figure 4. Oral Image Figure 5. External Use Image Figure 6. Other Image Figure 7. Global Candidiasis Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Candidiasis Drug Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Retail Pharmacy Image Figure 11. Other Image Figure 12. Global Candidiasis Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 14. Global Candidiasis Drug Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Candidiasis Drug Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Candidiasis Drug Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Candidiasis Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Candidiasis Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Candidiasis Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Candidiasis Drug Revenue Market Share by Application (2021-2032) Figure 23. North America Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 24. North America Candidiasis Drug Market Share by Type (2021-2032) Figure 25. North America Candidiasis Drug Market Share by Application (2021-2032) Figure 26. North America Candidiasis Drug Market Share by Country (2021-2032) Figure 27. United States Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 28. Canada Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 30. Europe Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 31. Europe Candidiasis Drug Market Share by Type (2021-2032) Figure 32. Europe Candidiasis Drug Market Share by Application (2021-2032) Figure 33. Europe Candidiasis Drug Market Share by Country (2021-2032) Figure 34. Germany Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 35. France Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 37. Italy Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 38. Russia Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 40. China Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 41. China Candidiasis Drug Market Share by Type (2021-2032) Figure 42. China Candidiasis Drug Market Share by Application (2021-2032) Figure 43. Asia Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 44. Asia Candidiasis Drug Market Share by Type (2021-2032) Figure 45. Asia Candidiasis Drug Market Share by Application (2021-2032) Figure 46. Asia Candidiasis Drug Market Share by Country (2021-2032) Figure 47. Japan Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 51. India Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 52. Australia Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Candidiasis Drug Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Candidiasis Drug Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Candidiasis Drug Market Share by Country (2021-2032) Figure 57. Brazil Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 62. UAE Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 64. Chile Candidiasis Drug Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • External Use
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Bristol-Myers Squibb
  • Cisen Pharmaceutical
  • Effik
  • Kingyork Group
  • Perrigo
  • Bayer
  • Pfizer
  • J & J
  • Sanofi
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Candidiasis Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 External Use
  6. 1.2.4 Other
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Candidiasis Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Retail Pharmacy
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Candidiasis Drug Growth Trends by Region
  14. 1.5.1 Global Candidiasis Drug Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Candidiasis Drug Market Size by Region (2021-2026)
  16. 1.5.3 Candidiasis Drug Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Candidiasis Drug Market Dynamics
  1. 2.1 Candidiasis Drug Industry Trends
  2. 2.2 Candidiasis Drug Industry Drivers
  3. 2.3 Candidiasis Drug Industry Opportunities and Challenges
  4. 2.4 Candidiasis Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Candidiasis Drug Revenue by Company (2021-2026)
  2. 3.2 Global Candidiasis Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Candidiasis Drug Key Company Head office and Area Served
  4. 3.4 Global Candidiasis Drug Company, Product Type & Application
  5. 3.5 Global Candidiasis Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Candidiasis Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Candidiasis Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Candidiasis Drug Tier 1, Tier 2, and Tier 3
4 Candidiasis Drug Market by Type
  1. 4.1 Global Candidiasis Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Candidiasis Drug Market Size by Type (2021-2032)
  3. 4.3 Global Candidiasis Drug Market Size Share by Type (2021-2032)
5 Candidiasis Drug Market by Application
  1. 5.1 Global Candidiasis Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Candidiasis Drug Market Size by Application (2021-2032)
  3. 5.3 Global Candidiasis Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb
  2. 6.1.1 Bristol-Myers Squibb Company Information
  3. 6.1.2 Bristol-Myers Squibb Business Overview
  4. 6.1.3 Bristol-Myers Squibb Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Candidiasis Drug Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Recent Developments
  7. 6.2 Cisen Pharmaceutical
  8. 6.2.1 Cisen Pharmaceutical Company Information
  9. 6.2.2 Cisen Pharmaceutical Business Overview
  10. 6.2.3 Cisen Pharmaceutical Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Cisen Pharmaceutical Candidiasis Drug Product Portfolio
  12. 6.2.5 Cisen Pharmaceutical Recent Developments
  13. 6.3 Effik
  14. 6.3.1 Effik Company Information
  15. 6.3.2 Effik Business Overview
  16. 6.3.3 Effik Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Effik Candidiasis Drug Product Portfolio
  18. 6.3.5 Effik Recent Developments
  19. 6.4 Kingyork Group
  20. 6.4.1 Kingyork Group Company Information
  21. 6.4.2 Kingyork Group Business Overview
  22. 6.4.3 Kingyork Group Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Kingyork Group Candidiasis Drug Product Portfolio
  24. 6.4.5 Kingyork Group Recent Developments
  25. 6.5 Perrigo
  26. 6.5.1 Perrigo Company Information
  27. 6.5.2 Perrigo Business Overview
  28. 6.5.3 Perrigo Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Perrigo Candidiasis Drug Product Portfolio
  30. 6.5.5 Perrigo Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bayer Candidiasis Drug Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pfizer Candidiasis Drug Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 J & J
  44. 6.8.1 J & J Company Information
  45. 6.8.2 J & J Business Overview
  46. 6.8.3 J & J Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 J & J Candidiasis Drug Product Portfolio
  48. 6.8.5 J & J Recent Developments
  49. 6.9 Sanofi
  50. 6.9.1 Sanofi Company Information
  51. 6.9.2 Sanofi Business Overview
  52. 6.9.3 Sanofi Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Sanofi Candidiasis Drug Product Portfolio
  54. 6.9.5 Sanofi Recent Developments
  55. 6.10 Teva
  56. 6.10.1 Teva Company Information
  57. 6.10.2 Teva Business Overview
  58. 6.10.3 Teva Candidiasis Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Teva Candidiasis Drug Product Portfolio
  60. 6.10.5 Teva Recent Developments
7 North America
  1. 7.1 North America Candidiasis Drug Market Size (2021-2032)
  2. 7.2 North America Candidiasis Drug Market Size by Type
  3. 7.2.1 North America Candidiasis Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Candidiasis Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Candidiasis Drug Market Share by Type (2021-2032)
  6. 7.3 North America Candidiasis Drug Market Size by Application
  7. 7.3.1 North America Candidiasis Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Candidiasis Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Candidiasis Drug Market Share by Application (2021-2032)
  10. 7.4 North America Candidiasis Drug Market Size by Country
  11. 7.4.1 North America Candidiasis Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Candidiasis Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Candidiasis Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Candidiasis Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Candidiasis Drug Market Size (2021-2032)
  2. 8.2 Europe Candidiasis Drug Market Size by Type
  3. 8.2.1 Europe Candidiasis Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Candidiasis Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Candidiasis Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Candidiasis Drug Market Size by Application
  7. 8.3.1 Europe Candidiasis Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Candidiasis Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Candidiasis Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Candidiasis Drug Market Size by Country
  11. 8.4.1 Europe Candidiasis Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Candidiasis Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Candidiasis Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Candidiasis Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Candidiasis Drug Market Size (2021-2032)
  2. 9.2 China Candidiasis Drug Market Size by Type
  3. 9.2.1 China Candidiasis Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Candidiasis Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Candidiasis Drug Market Share by Type (2021-2032)
  6. 9.3 China Candidiasis Drug Market Size by Application
  7. 9.3.1 China Candidiasis Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Candidiasis Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Candidiasis Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Candidiasis Drug Market Size (2021-2032)
  2. 10.2 Asia Candidiasis Drug Market Size by Type
  3. 10.2.1 Asia Candidiasis Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Candidiasis Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Candidiasis Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Candidiasis Drug Market Size by Application
  7. 10.3.1 Asia Candidiasis Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Candidiasis Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Candidiasis Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Candidiasis Drug Market Size by Country
  11. 10.4.1 Asia Candidiasis Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Candidiasis Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Candidiasis Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Candidiasis Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Candidiasis Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Candidiasis Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Candidiasis Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Candidiasis Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Candidiasis Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Candidiasis Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Candidiasis Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Candidiasis Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Candidiasis Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Candidiasis Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Candidiasis Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Candidiasis Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Candidiasis Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Candidiasis Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst